Inhibition of the ER Ca2+ pump forces multidrug-resistant cells deficient in Bak and Bax into necrosis

Journal of Cell Science
Katja JanssenUte Fischer

Abstract

Tumor cells deficient in the proapoptotic proteins Bak and Bax are resistant to chemotherapeutic drugs. Here, we demonstrate that murine embryonic fibroblasts deficient for both Bak and Bax are, however, efficiently killed by thapsigargin, a specific inhibitor of ER Ca(2+) pumps that induces ER stress by depleting ER Ca(2+) stores. In the presence of Bak and Bax, thapsigargin eliminates cells by release of mitochondrial cytochrome c and subsequent caspase activation, which leads to the proteolytic inactivation of the molecular necrosis switch PARP-1 and results in apoptosis. By contrast, in the absence of Bak and Bax, a failure to activate caspases results in PARP-1-mediated ATP depletion. The subsequent necrosis is not prevented by autophagy as an alternative energy source. Moreover, in cells deficient for both Bak and Bax, thapsigargin induces permanent mitochondrial damage by Ca(2+) overload, permeability transition and membrane rupture. Thus, even though deficiency in Bak and Bax protects these cells against apoptosis, it does not compromise necrosis induced by SERCA inhibitors. Importantly, thapsigargin induces caspase-independent cell death also in colon and prostate carcinoma cells deficient in Bak and Bax expression. Th...Continue Reading

References

Aug 28, 1998·Science·D R Green, J C Reed
Oct 17, 1998·Molecular Cell·H NishitohH Ichijo
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I SturmP T Daniel
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·H C Ha, S H Snyder
May 16, 2000·The Journal of Biological Chemistry·G SzalaiG Hajnóczky
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y IonovM Perucho
Jul 12, 2001·The Journal of Biological Chemistry·G Q WangH Rabinowich
Jul 12, 2002·Nature·Paola ScaffidiMarco E Bianchi
Jun 20, 2003·Cell Death and Differentiation·N J Waterhouse, J A Trapani
Jul 3, 2003·Journal of the National Cancer Institute·Samuel R DenmeadeJohn T Isaacs
Aug 3, 2004·Science·Douglas R Green, Guido Kroemer
Jan 22, 2005·Cancer Biology & Therapy·Samuel R Denmeade, John T Isaacs
Jun 7, 2005·Nature Structural & Molecular Biology·Anne-Catrin UhlemannSanjeev Krishna
Jun 15, 2005·Annual Review of Biochemistry·Martin Schröder, Randal J Kaufman
Oct 4, 2005·The Journal of Clinical Investigation·Chunyan XuJohn C Reed
Oct 4, 2005·The Journal of Clinical Investigation·Beth Levine, Junying Yuan
Jan 7, 2006·Cell Death and Differentiation·M Boyce, J Yuan
May 6, 2006·Cell Death and Differentiation·T Lindsten, C B Thompson
Jul 21, 2006·American Journal of Physiology. Cell Physiology·Charles W BellDavid S Pisetsky
Sep 6, 2006·EMBO Reports·Eva SzegezdiAfshin Samali
Oct 13, 2006·Nature·Mariusz KarbowskiRichard J Youle
Jan 24, 2007·Physiological Reviews·Guido KroemerCatherine Brenner
Jul 3, 2007·Cell·Hamsa PuthalakathAndreas Strasser
Jul 7, 2007·Cell Death and Differentiation·M Høyer-Hansen, M Jäättelä

❮ Previous
Next ❯

Citations

Mar 29, 2011·Cold Spring Harbor Perspectives in Biology·Djalila MekahliLudwig Missiaen
Nov 14, 2013·Apoptosis : an International Journal on Programmed Cell Death·Mahendra SeerviT R Santhoshkumar
Sep 4, 2014·Apoptosis : an International Journal on Programmed Cell Death·Meng-Liang LinTian-Shung Wu
Nov 21, 2015·The FEBS Journal·Raffaella Iurlaro, Cristina Muñoz-Pinedo
Jul 24, 2010·Annals of the New York Academy of Sciences·Yulia Kushnareva, Donald D Newmeyer
May 1, 2015·Cell Cycle·Kewei Wang
Oct 28, 2011·World Journal of Biological Chemistry·Yan Cheng, Jin-Ming Yang
Apr 15, 2016·Journal of Cell Science·Stephanie Einsele-ScholzFrank Essmann
Dec 29, 2017·Biological Reviews of the Cambridge Philosophical Society·Anutosh Chakraborty
Sep 15, 2012·Experimental and Therapeutic Medicine·Shaoxiang WengHe Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.